Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.
about
Hepatic hemodynamic changes during liver transplantation: a reviewSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisRethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionReview article: a drug therapy for the prevention of variceal haemorrhage.Clinical pharmacology of portal hypertension.Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver.The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosisInflammation: a way to understanding the evolution of portal hypertension.Animal models of portal hypertensionEvolutive phases of experimental prehepatic portal hypertension.The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.Portal hypertension--25 years of progressOverview of the methods and therapies for the primary prevention of variceal bleeding.Hemodynamic assessment of the development of portal-systemic collaterals in portal hypertensive rats.Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis.Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive ratsEndocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs.Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation.Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.Effect of verapamil on splanchnic haemodynamics in a portal hypertensive rat model.Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats
P2860
Q26822255-E44B0EF7-5EAF-4F7E-9FEA-37008182EEFCQ27013775-EF0D6B55-950E-455A-B38C-ED91805C5EA7Q28069136-6DB0F7CE-50CE-457D-B3C3-9E99C2D9AA14Q34156200-52DB9EC1-7F6A-4F60-84BE-6E61BFA00305Q34399357-D45209C7-DEBE-41F4-AE33-FEFF3C3F0DBBQ34533948-75052A89-3B05-4D69-9E50-97881F462A46Q35761323-41ED8051-A215-485C-858A-1AC725EBCD48Q36391634-BF40E39D-73A7-4E73-BBDA-4CAFB8E2AC57Q36640036-61A7E95E-9584-44B4-BC98-53971078D35AQ36869392-FF5D9EFC-74AF-41A1-9CD4-9236C5EA20C1Q36950557-A49593B3-1418-402B-A1A4-CE14E58C5192Q37327436-0414F046-A546-466E-8975-07FEF4C246F7Q37375679-A78959AF-B552-4DD4-9F44-6E7FA6B2FE41Q37777150-6396A7FD-D344-4060-9390-35FB0A38637EQ39856428-D4FE32C7-0FC7-4365-A736-309B5C973999Q40476947-6235DC96-E67F-477F-8162-53A67AE47DE8Q41564166-EF19A49E-C4A5-4A14-BDE3-024980188293Q41973649-6B1A3309-8EB8-4D36-A581-F0E8A2F989F0Q42176897-5A891F39-79A4-4EFF-AEE8-7021473C86F2Q43658822-E0F0A556-2035-48D4-A60A-86E8268AC31AQ43773067-6638C15C-356C-4658-94FD-7CE7B91EB508Q43904253-B806661C-64D1-40D6-917D-E94CBDBEBCAAQ45046905-791EEB30-856D-4665-912C-0DF322B3F39AQ48220078-0C008C8D-4E25-45FC-A48E-DE69F4B71B97Q49069784-82D851E0-D58E-4917-BDA0-87382025CABCQ50436282-9A25EDF8-6298-4BAF-AD68-B8327F67C66DQ54329944-1913CA21-3748-4F8B-A5B8-CEF6B2CAE178Q55038505-3BE97B8F-72D9-4D0A-861E-52F92748B1CCQ55174085-3CC664D8-11CF-4E58-8DC2-24D78B4F9497
P2860
Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Increased portal venous resist ...... n a portal hypertensive model.
@en
Increased portal venous resist ...... n a portal hypertensive model.
@nl
type
label
Increased portal venous resist ...... n a portal hypertensive model.
@en
Increased portal venous resist ...... n a portal hypertensive model.
@nl
prefLabel
Increased portal venous resist ...... n a portal hypertensive model.
@en
Increased portal venous resist ...... n a portal hypertensive model.
@nl
P356
P1433
P1476
Increased portal venous resist ...... n a portal hypertensive model.
@en
P2093
Groszmann RJ
Kroeger RJ
P304
P356
10.1002/HEP.1840050120
P407
P577
1985-01-01T00:00:00Z